PHARMCO II ApS: Financial statements 2023
CVR: 25202899
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PHARMCO II ApS (CVR 25202899) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -47,250 and a net result of DKK 12,970,391 compared with DKK -1,724,091 the year before. Equity in the 2023 report amounted to DKK 85,088,768. The solvency ratio was 77.8%. The company had 65 employees in the financial year.
- Gross Profit
- DKK -47,250
- Profit/Loss
- DKK 12,970,391
- Equity
- DKK 85,088,768
- Total Assets
- DKK 109,402,812
- Employees
- 65
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -47 t. | 13 mio. | 85.1 mio. | 65 |
| 2022 | - | 0 | -1.7 mio. | 72.1 mio. | 63 |
| 2021 | - | 0 | 4.2 mio. | 73.8 mio. | 49 |
| 2020 | - | -20 t. | 2.8 mio. | 69.7 mio. | 48 |
| 2019 | - | -19 t. | 1.5 mio. | 66.9 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PHARMCO II ApS has published its annual report for 2022. Gross profit came to DKK 0, and the net result was DKK -1,724,091.
About PHARMCO II ApS
PHARMCO II ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK -56,000 and a net result of DKK 34,432,000 compared with DKK 7,096,622 the year before. Equity in the 2025 report amounted to DKK 107,079,000.